Baseret på stigningen i IC50 forekom ZDV- resistens lavere i VIRAMUNE + ZDV + ddl- gruppen end i de andre behandlingsgrupper.
Based on the increase in IC50, zidovudine resistance appeared lower in the VIRAMUNE + zidovudine + didanosine group than the other treatment groups.